SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001144204-14-035238
Filing Date
2014-06-03
Accepted
2014-06-03 10:33:25
Documents
1
Group Members
DON A. SANDERSJAMES C. GALELIFE SCIENCES OPPORTUNITIES FUND II (INSTITUTIONAL), L.P.SIGNET HEALTHCARE PARTNERS, LLCSMW INVESTMENTS I, LLCSOF MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 v380220_sc13da.htm SC 13D/A 158165
  Complete submission text file 0001144204-14-035238.txt   160039
Mailing Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223
Business Address 7180 SW SANDBURG STREET, SUITE 100 TIGARD OR 97223 503-692-8001
BIOJECT MEDICAL TECHNOLOGIES INC (Subject) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-40150 | Film No.: 14886242
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 126 E 56TH STREET 28TH FL NEW YORK NY 10022
Business Address 126 EAST 56TH STREET NEW YORK NY 10022 212-419-3900
LIFE SCIENCES OPPORTUNITIES FUND II LP (Filed by) CIK: 0001269415 (see all company filings)

IRS No.: 571190948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A